{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:43:13Z","timestamp":1780321393193,"version":"3.54.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva, vedy, v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","award":["0395\/2016"],"award-info":[{"award-number":["0395\/2016"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003193","name":"Ministerstvo \u0161kolstva, vedy, v\u00fdskumu a \u0161portu Slovenskej republiky","doi-asserted-by":"publisher","award":["2015-15075\/33841:1-15E0"],"award-info":[{"award-number":["2015-15075\/33841:1-15E0"]}],"id":[{"id":"10.13039\/501100003193","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["SAF-2013-48971-C2-2-R"],"award-info":[{"award-number":["SAF-2013-48971-C2-2-R"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["12001407"],"award-info":[{"award-number":["12001407"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ITMS 26240120027"],"award-info":[{"award-number":["ITMS 26240120027"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-10-EQPX-04-01"],"award-info":[{"award-number":["ANR-10-EQPX-04-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["260872"],"award-info":[{"award-number":["260872"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.tube.2018.08.004","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T19:49:48Z","timestamp":1534016988000},"page":"98-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase"],"prefix":"10.1016","volume":"112","author":[{"given":"Giorgia","family":"Mori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Silvia","family":"Orena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Franch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley A.","family":"Mitchenall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwait Anand","family":"Godbole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7438-9141","authenticated-orcid":false,"given":"Clara","family":"Aguilar-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falia","family":"Zemanov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislav","family":"Husz\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Forbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2873-5485","authenticated-orcid":false,"given":"Nathalie","family":"Deboosere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-3197","authenticated-orcid":false,"given":"Rosangela","family":"Frita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vandeputte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4224-1091","authenticated-orcid":false,"given":"Eik","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Veilleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7439-1321","authenticated-orcid":false,"given":"Rajiv K.","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel S.","family":"Freundlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0991-7344","authenticated-orcid":false,"given":"Priscille","family":"Brodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-844X","authenticated-orcid":false,"given":"Jose Antonio","family":"A\u00ednsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valakunja","family":"Nagaraja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5756-6430","authenticated-orcid":false,"given":"Anthony","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katar\u00edna","family":"Miku\u0161ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8906-4937","authenticated-orcid":false,"given":"Maria Rosalia","family":"Pasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5691-5790","authenticated-orcid":false,"given":"Sean","family":"Ekins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2018.08.004_bib1","series-title":"Global tuberculosis report 2016","author":"Anon","year":"2016"},{"key":"10.1016\/j.tube.2018.08.004_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMsr1512438","article-title":"Twenty years of global surveillance of antituberculosis-drug resistance","volume":"375","author":"Zignol","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2018.08.004_bib3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1146\/annurev.pharmtox.45.120403.100120","article-title":"The magic bullets and tuberculosis drug targets","volume":"45","author":"Zhang","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.tube.2018.08.004_bib4","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/AAC.49.6.2153-2163.2005","article-title":"New small-molecule synthetic antimycobacterials","volume":"49","author":"Ballel","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib5","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1473-3099(13)70328-1","article-title":"New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects","volume":"14","author":"Zumla","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2018.08.004_bib6","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1021\/acs.jcim.6b00004","article-title":"Machine learning model analysis and data visualization with small molecules tested in a mouse model of Mycobacterium tuberculosis infection (2014-2015)","volume":"56","author":"Ekins","year":"2016","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.tube.2018.08.004_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.drudis.2016.09.025","article-title":"Learning from the past for TB drug discovery in the future","volume":"22","author":"Mikusova","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tube.2018.08.004_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.drudis.2016.09.012","article-title":"Raising awareness of the importance of funding for tuberculosis small-molecule research","volume":"22","author":"Riccardi","year":"2016","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tube.2018.08.004_bib9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.drudis.2011.02.016","article-title":"In silico repositioning of approved drugs for rare and neglected diseases","volume":"16","author":"Ekins","year":"2011","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tube.2018.08.004_bib10","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1007\/s11095-011-0486-6","article-title":"Finding promiscuous old drugs for new uses","volume":"28","author":"Ekins","year":"2011","journal-title":"Pharm Res"},{"key":"10.1016\/j.tube.2018.08.004_bib11","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1021\/acs.molpharmaceut.6b00248","article-title":"Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data","volume":"13","author":"Aliper","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.tube.2018.08.004_bib12","doi-asserted-by":"crossref","first-page":"27792","DOI":"10.1038\/srep27792","article-title":"Predictive modeling targets thymidylate synthase ThyX in Mycobacterium tuberculosis","volume":"6","author":"Djaout","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2018.08.004_bib13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.tube.2018.08.004_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The Connectivity Map: a new tool for biomedical research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.tube.2018.08.004_bib15","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tube.2009.07.002","article-title":"New anti-tuberculosis agents amongst known drugs","volume":"89","author":"Lougheed","year":"2009","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2018.08.004_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.chembiol.2013.01.011","article-title":"Bayesian models leveraging bioactivity and cytotoxicity information for drug discovery","volume":"20","author":"Ekins","year":"2013","journal-title":"Chem Biol"},{"key":"10.1016\/j.tube.2018.08.004_bib17","article-title":"Mefloquine and its enantiomers are active against Mycobacterium tuberculosis in vitro and in macrophages","volume":"2014","author":"Bermudez","year":"2014","journal-title":"Tuberc Res Treat"},{"key":"10.1016\/j.tube.2018.08.004_bib18","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1128\/AAC.49.9.3707-3714.2005","article-title":"Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteria","volume":"49","author":"Danelishvili","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib19","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1038\/ncomms8659","article-title":"Lansoprazole is an antituberculous prodrug targeting cytochrome bc1","volume":"6","author":"Rybniker","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.tube.2018.08.004_bib20","first-page":"31","article-title":"Lansoprazole-sulfide, pharmacokinetics of this promising anti-tuberculous agent","author":"Mdanda","year":"2017","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.tube.2018.08.004_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0035-9203(92)90414-8","article-title":"Studies on a new antimalarial compound: pyronaridine","volume":"86","author":"Chang","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.tube.2018.08.004_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1475-2875-11-270","article-title":"Review of pyronaridine anti-malarial properties and product characteristics","volume":"11","author":"Croft","year":"2012","journal-title":"Malar J"},{"key":"10.1016\/j.tube.2018.08.004_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s13318-014-0182-0","article-title":"Mass balance and metabolism of the antimalarial pyronaridine in healthy volunteers","volume":"40","author":"Morris","year":"2015","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"10.1016\/j.tube.2018.08.004_bib24","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.bbrc.2014.03.029","article-title":"Inhibition of Mycobacterium tuberculosis topoisomerase I by m-AMSA, a eukaryotic type II topoisomerase poison","volume":"446","author":"Godbole","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tube.2018.08.004_bib25","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1128\/AAC.04516-14","article-title":"Targeting Mycobacterium tuberculosis topoisomerase I by small-molecule inhibitors","volume":"59","author":"Godbole","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tube.2017.01.005","article-title":"Machine learning and docking models for Mycobacterium tuberculosis topoisomerase I","volume":"103","author":"Ekins","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2018.08.004_bib27","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1128\/AAC.46.8.2720-2722.2002","article-title":"Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis","volume":"46","author":"Palomino","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib28","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"WHO","year":"2017"},{"key":"10.1016\/j.tube.2018.08.004_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluating antimicrobial activity: a review","volume":"6","author":"Balouiri","year":"2016","journal-title":"J Pharmaceut Anal"},{"key":"10.1016\/j.tube.2018.08.004_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib31","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1469-0691.2000.00149.x","article-title":"EUCAST Definitive Document E.Def 1.2, May 2000: terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents","volume":"6","author":"(ESCMID) ESoCMaID","year":"2000","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.tube.2018.08.004_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2018.08.004_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/cyto.a.23129","article-title":"Phenotypic assays for Mycobacterium tuberculosis infection","volume":"91","author":"Song","year":"2017","journal-title":"Cytometry A"},{"key":"10.1016\/j.tube.2018.08.004_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/978-1-4939-2450-9_13","article-title":"Measuring efflux and permeability in mycobacteria","volume":"1285","author":"Rodrigues","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.tube.2018.08.004_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.molcel.2017.03.001","article-title":"Structural basis of Mycobacterium tuberculosis transcription and transcription inhibition","volume":"66","author":"Lin","year":"2017","journal-title":"Mol Cell"},{"key":"10.1016\/j.tube.2018.08.004_bib36","doi-asserted-by":"crossref","first-page":"9774","DOI":"10.1093\/nar\/gks704","article-title":"The role of Ca(2)(+) in the activity of Mycobacterium tuberculosis DNA gyrase","volume":"40","author":"Karkare","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tube.2018.08.004_bib37","doi-asserted-by":"crossref","first-page":"19648","DOI":"10.1016\/S0021-9258(19)47162-7","article-title":"Tryptic fragments of the Escherichia coli DNA gyrase A protein","volume":"264","author":"Reece","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib38","doi-asserted-by":"crossref","first-page":"13925","DOI":"10.1074\/jbc.273.22.13925","article-title":"DNA topoisomerase I from Mycobacterium smegmatis. An enzyme with distinct features","volume":"273","author":"Bhaduri","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib39","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1099\/mic.0.036970-0","article-title":"Novel insertion and deletion mutants of RpoB that render Mycobacterium smegmatis RNA polymerase resistant to rifampicin-mediated inhibition of transcription","volume":"156","author":"Malshetty","year":"2010","journal-title":"Microbiology"},{"key":"10.1016\/j.tube.2018.08.004_bib40","doi-asserted-by":"crossref","first-page":"8235","DOI":"10.1021\/bi00026a004","article-title":"Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis","volume":"34","author":"Quemard","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.tube.2018.08.004_bib41","doi-asserted-by":"crossref","first-page":"6308","DOI":"10.1021\/jm060715y","article-title":"Pyrrolidine carboxamides as a novel class of inhibitors of enoyl acyl Carrier protein reductase from Mycobacterium tuberculosis","volume":"49","author":"He","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib42","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acsinfecdis.7b00006","article-title":"A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors","volume":"3","author":"Esposito","year":"2017","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.tube.2018.08.004_bib43","doi-asserted-by":"crossref","first-page":"25523","DOI":"10.1038\/srep25523","article-title":"BRAID: a unifying paradigm for the analysis of combined drug action","volume":"6","author":"Twarog","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.tube.2018.08.004_bib44","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nm.3458","article-title":"Spectinamides: a new class of semisynthetic antituberculosis agents that overcome native drug efflux","volume":"20","author":"Lee","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2018.08.004_bib45","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1128\/JCM.01944-12","article-title":"Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype","volume":"51","author":"Villellas","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.tube.2018.08.004_bib46","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1128\/AAC.05946-11","article-title":"Functional and genetic characterization of the tap efflux pump in Mycobacterium bovis BCG","volume":"56","author":"Ramon-Garcia","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib47","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.1128\/JB.180.22.5836-5843.1998","article-title":"Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis","volume":"180","author":"Ainsa","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.tube.2018.08.004_bib48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tube.2018.08.004_bib49","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1128\/AAC.00550-09","article-title":"Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth","volume":"53","author":"Ramon-Garcia","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005351","article-title":"Mycobacterial metabolic syndrome: LprG and Rv1410 regulate triacylglyceride levels, growth rate and virulence in Mycobacterium tuberculosis","volume":"12","author":"Martinot","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.tube.2018.08.004_bib51","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1128\/AAC.01482-12","article-title":"Role of the Mmr efflux pump in drug resistance in Mycobacterium tuberculosis","volume":"57","author":"Rodrigues","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib52","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1574-6976.2005.00002.x","article-title":"Role of mycobacterial efflux transporters in drug resistance: an unresolved question","volume":"30","author":"De Rossi","year":"2006","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.tube.2018.08.004_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.drudis.2017.01.002","article-title":"Antituberculosis drugs: reducing efflux=increasing activity","volume":"22","author":"Rodrigues","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tube.2018.08.004_bib54","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.bbrc.2004.05.099","article-title":"Pyronaridine, a novel modulator of P-glycoprotein-mediated multidrug resistance in tumor cells in vitro and in vivo","volume":"319","author":"Qi","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tube.2018.08.004_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1126\/science.1171583","article-title":"Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis","volume":"324","author":"Makarov","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.tube.2018.08.004_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056980","article-title":"Improved BM212 MmpL3 inhibitor analogue shows efficacy in acute murine model of tuberculosis infection","volume":"8","author":"Poce","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2018.08.004_bib57","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chembiol.2015.05.016","article-title":"Thiophenecarboxamide derivatives activated by EthA kill Mycobacterium tuberculosis by inhibiting the CTP synthetase PyrG","volume":"22","author":"Mori","year":"2015","journal-title":"Chem Biol"},{"key":"10.1016\/j.tube.2018.08.004_bib58","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1021\/cb500149m","article-title":"Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis","volume":"9","author":"Albesa-Jove","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.tube.2018.08.004_bib59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2013.06.042","article-title":"Synthesis and evaluation of alpha-ketotriazoles and alpha,beta-diketotriazoles as inhibitors of Mycobacterium tuberculosis","volume":"69","author":"Menendez","year":"2013","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib60","doi-asserted-by":"crossref","first-page":"7645","DOI":"10.1021\/bi0008940","article-title":"Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid","volume":"39","author":"Parikh","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.tube.2018.08.004_bib61","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.74.11.4772","article-title":"Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity","volume":"74","author":"Gellert","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2018.08.004_bib62","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1073\/pnas.74.11.4767","article-title":"Mechanism of action of nalidixic acid: purification of Escherichia coli nalA gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme","volume":"74","author":"Sugino","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2018.08.004_bib63","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/AAC.05454-11","article-title":"Baseline in vitro activities of the antimalarials pyronaridine and methylene blue against Plasmodium falciparum isolates from Kenya","volume":"56","author":"Okombo","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib64","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.actatropica.2007.12.005","article-title":"Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo","volume":"105","author":"Vivas","year":"2008","journal-title":"Acta Trop"},{"key":"10.1016\/j.tube.2018.08.004_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1988.38.30","article-title":"Morphological effects of pyronaridine on malarial parasites","volume":"38","author":"Wu","year":"1988","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tube.2018.08.004_bib66","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/AAC.00119-06","article-title":"Targeting of hematin by the antimalarial pyronaridine","volume":"50","author":"Auparakkitanon","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0006-2952(97)00510-8","article-title":"An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials","volume":"55","author":"Dorn","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.tube.2018.08.004_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0006-2952(99)00059-3","article-title":"Kinetics of inhibition of glutathione-mediated degradation of ferriprotoporphyrin IX by antimalarial drugs","volume":"58","author":"Famin","year":"1999","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.tube.2018.08.004_bib69","doi-asserted-by":"crossref","first-page":"11865","DOI":"10.1073\/pnas.93.21.11865","article-title":"On the molecular mechanism of chloroquine's antimalarial action","volume":"93","author":"Sullivan","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tube.2018.08.004_bib70","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1021\/acs.accounts.6b00631","article-title":"Insights into integrated lead generation and target identification in malaria and tuberculosis drug discovery","volume":"50","author":"Okombo","year":"2017","journal-title":"Acc Chem Res"},{"issue":"4","key":"10.1016\/j.tube.2018.08.004_bib71","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01834-17","article-title":"Identification of anti-trypanosoma cruzi lead compounds with putative immunomodulatory activity","volume":"62","author":"Otta","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125276","article-title":"Optimization of a fluorescence-based assay for large-scale drug screening against Babesia and theileria parasites","volume":"10","author":"Rizk","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2018.08.004_bib73","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.12688\/f1000research.7217.1","article-title":"Machine learning models identify molecules active against Ebola virus in vitro","volume":"4","author":"Ekins","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/j.tube.2018.08.004_bib74","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.bbrc.2006.07.017","article-title":"First functional characterization of a singly expressed bacterial type II topoisomerase: the enzyme from Mycobacterium tuberculosis","volume":"348","author":"Aubry","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.tube.2018.08.004_bib75","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1093\/nar\/30.10.2144","article-title":"Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase","volume":"30","author":"Manjunatha","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.tube.2018.08.004_bib76","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1128\/AAC.37.3.403","article-title":"Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro","volume":"37","author":"Chavalitshewinkoon","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006754","article-title":"Transcription facilitated genome-wide recruitment of topoisomerase I and DNA gyrase","volume":"13","author":"Ahmed","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/j.tube.2018.08.004_bib78","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.drudis.2016.11.006","article-title":"DNA topoisomerase I and DNA gyrase as targets for TB therapy","volume":"22","author":"Nagaraja","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.tube.2018.08.004_bib79","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1093\/jac\/dkx152","article-title":"In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis","volume":"72","author":"Kaushik","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib80","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/jac\/dkx081","article-title":"Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial","volume":"72","author":"Gurumurthy","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2016.11.048","article-title":"New insights into the SAR and drug combination synergy of 2-(quinolin-4-yloxy)acetamides against Mycobacterium tuberculosis","volume":"126","author":"Giacobbo","year":"2017","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib82","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/iub.1526","article-title":"Design, synthesis, and in vitro antituberculosis activity of 2(5H)-Furanone derivatives","volume":"68","author":"Ngwane","year":"2016","journal-title":"IUBMB Life"},{"key":"10.1016\/j.tube.2018.08.004_bib83","doi-asserted-by":"crossref","first-page":"6232","DOI":"10.1021\/acs.jmedchem.6b00415","article-title":"Indole-2-carboxamide-based MmpL3 inhibitors show exceptional antitubercular activity in an animal model of tuberculosis infection","volume":"59","author":"Stec","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/j.tube.2018.08.004_bib84","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1128\/AAC.04271-14","article-title":"The efflux pump inhibitor timcodar improves the potency of antimycobacterial agents","volume":"59","author":"Grossman","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"10.1016\/j.tube.2018.08.004_bib85","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.tube.2014.09.002","article-title":"Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy","volume":"94","author":"de Knegt","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2018.08.004_bib86","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1093\/jac\/dkr355","article-title":"Characterization of 7-amino-4-methylcoumarin as an effective antitubercular agent: structure-activity relationships","volume":"66","author":"Tandon","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2018.08.004_bib87","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1021\/cb5007163","article-title":"2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1","volume":"10","author":"Neres","year":"2015","journal-title":"ACS Chem Biol"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218300088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979218300088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:59:21Z","timestamp":1778813961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979218300088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":87,"alternative-id":["S1472979218300088"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2018.08.004","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2018.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}